Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database

Several systems (tumor‐node‐metastasis [TNM], Barcelona Clinic Liver Cancer [BCLC], Okuda, Cancer of the Liver Italian Program [CLIP], and albumin–bilirubin grade [ALBI]) were developed to estimate the prognosis of patients with hepatocellular carcinoma (HCC) mostly prior to the prevalent use of sor...

Descripción completa

Detalles Bibliográficos
Autores principales: Samawi, Haider H., Sim, Hao‐Wen, Chan, Kelvin K., Alghamdi, Mohammad A., Lee‐Ying, Richard M., Knox, Jennifer J., Gill, Parneet, Romagnino, Adriana, Batuyong, Eugene, Ko, Yoo‐Joung, Davies, Janine M., Lim, Howard J., Cheung, Winson Y., Tam, Vincent C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051235/
https://www.ncbi.nlm.nih.gov/pubmed/29766659
http://dx.doi.org/10.1002/cam4.1493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051235/
https://www.ncbi.nlm.nih.gov/pubmed/29766659
http://dx.doi.org/10.1002/cam4.1493

Ejemplares similares